Elevated Depressive Symptoms Increase Adverse Outcome Risk in Nondialysis Chronic Kidney Disease
The following is a summary of “Depressive Symptoms, Antidepressants, and Clinical Outcomes in...
Read MoreMay 17, 2024
The following is a summary of “Depressive Symptoms, Antidepressants, and Clinical Outcomes in...
Read MoreMay 3, 2024
Use of sodium–glucose cotransporter-2 inhibitors (SGLT2is) is associated with a substantially...
Read MoreApr 9, 2024
The following is a summary of “Chronic kidney disease in inflammatory bowel disease, a systematic...
Read MoreApr 8, 2024
The anti-aging protein Klotho plays a protective role in kidney disease, but its potential as a biomarker for chronic kidney disease (CKD) is controversial. Additionally, the main pathways through which Klotho exerts its effects...
Read MoreMar 25, 2024
Monocyte to high-density lipoprotein cholesterol ratio (MHR) was confirmed as a novel inflammatory...
Read MoreMar 20, 2024
The following is a summary of “Daprodustat and Heart Failure in CKD,” published in the February...
Read MoreMar 13, 2024
The following is a summary of “Low rate of severe-end-stage kidney disease after SABR for...
Read MoreMar 11, 2024
Famine exposure in childhood is proven to be associated with multiple chornic disease in adult but has not been studied with chronic kidney disease (CKD).This study was conducted to identify the relationship between famine...
Read MoreMar 7, 2024
Hyperphosphatemia is common in chronic kidney disease (CKD), associated with higher mortality in dialysis patients. Its impact in non-dialysis patients, especially those with preserved kidney function, remains uncertain.A...
Read MoreMar 7, 2024
There are evidence indicating that some metabolites of arachidonic acid produced by cytochromes P450 (CYP) and epoxide hydroxylase (EPHX2), such as hydroxyeicosatetraenoic acids (HETEs), epoxyeicosatrienoic acids (EETs) or...
Read MoreMar 7, 2024
Kidney supportive care is an interdisciplinary model of person-centred medicine, suitable for patients with advanced Chronic Kidney Disease (CKD) and with End-Stage Kidney Disease (ESKD). There is little information on routine...
Read MoreMar 7, 2024
Accelerated neuropathy is a rare syndrome of rapidly worsening peripheral neuropathy, typically described in end-stage kidney disease (ESKD) patients undergoing dialysis. In our center, we encountered a surge in the occurrence...
Read MoreMar 4, 2024
There is no consensus on the physiologic decline in estimated glomerular filtration rate (GFR) due to geriatric conditions related with the aging or chronic kidney disease (CKD) itself. In this study, we aimed to compare the CKD...
Read MoreMar 4, 2024
Diabetic nephropathy is one of the most common complications associated with diabetes. However, non-diabetic kidney disease has been reported in patients with type 2 diabetes at varying incidence rates. The objective of our...
Read MoreMar 4, 2024
Chronic kidney disease (CKD) guidelines recommend early identification and intervention to delay the progression of CKD. The Kidney Disease: Improving Global Outcomes (KDIGO) heatmap is widely used for risk evaluation in CKD...
Read MoreFeb 28, 2024
The following is a summary of “Identifying individuals at risk of needing CKD associated...
Read MoreFeb 26, 2024
Iron deficiency anemia (IDA) increases levels of C-terminal fibroblast growth factor 23 (cFGF23) and platelet count (PLT), each of which is associated with cardiovascular events. Therefore, we hypothesized that iron replacement...
Read MoreFeb 19, 2024
The relationship of whole grain intake with chronic kidney disease (CKD) remains uncertain.This study aimed to evaluate the association between whole grain intake and the risk of CKD in Chinese adults.The present cross-sectional...
Read MoreFeb 19, 2024
Sodium-glucose cotransporter 2 inhibitors decrease blood pressure in patients with type 2 diabetes, but the consistency and magnitude of blood pressure lowering with dapagliflozin in patients with chronic kidney disease (CKD) is...
Read MoreFeb 12, 2024
Pulmonary hypertension (PH) is a complication of chronic kidney disease (CKD) that contributes to mortality. Sclerostin, a SOST gene product that reduces osteoblastic bone formation by inhibiting Wnt/β-catenin signaling, is...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.